Freestone Grove Partners LP Glaukos Corp Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Glaukos Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 219,810 shares of GKOS stock, worth $18.8 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
219,810Holding current value
$18.8 Million% of portfolio
0.17%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
332Shares Held
54.3MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$686 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$522 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$277 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$178 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$171 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.06B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...